The global blood grouping reagents market reached a value of USD 1,972.26 million in 2023 and is projected to reach USD 3,570.19 million by 2031. This translates to a steady Compound Annual Growth Rate (CAGR) of 7.7% from 2024 to 2031. This press release explores the key factors influencing market growth, regional variations, and offers valuable takeaways for industry stakeholders....

The global cardiovascular devices market is experiencing significant growth, reaching a value of USD 51.97 billion in 2023 and projected to reach USD 90.63 billion by 2031. This translates to a compelling Compound Annual Growth Rate (CAGR) of 7.2% from 2024 to 2031. This press release explores the key factors driving this growth, analyzes regional trends, and offers valuable insights...

Cardiovascular Devices  Market Share Scope & Overview The Cardiovascular Devices market research report covers a wide range of topics, such as potential customers, sales and competitive environment studies, projected product releases, ongoing and new technological breakthroughs, revenue and trade regulation evaluations, and much more. There are emerging and rapidly...

The global peptic ulcer drugs market, valued at USD 4.3 billion in 2023, is poised for substantial growth, with projections indicating it will reach USD 6.26 billion by 2031. This represents a compound annual growth rate (CAGR) of 4.81% over the forecast period from 2024 to 2031 Key Players The major players in Peptic Ulcer Drugs Market are AstraZeneca plc, Abbott...